HeartSciences (HSCS) Free Cash Flow (2021 - 2026)

HeartSciences (HSCS) has reported Free Cash Flow for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• Quarterly Free Cash Flow fell 5.4% year-over-year to -$1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$6.0 million (up 19.54% YoY) and the FY2026 annual result came in at -$7.4 million, changed 0.19% from the prior year.
• Free Cash Flow grew to -$1.7 million in Q2 2026 per HSCS's latest filing, from -$2.3 million in the prior quarter.
• Over the last five years, Free Cash Flow for HSCS reached as high as -$966278.0 in Q1 2022 and fell as low as -$2.3 million in Q4 2025.
• A 5-year average of -$1.6 million and a median of -$1.6 million in 2024 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow plunged 153.52% — and 2025, when it grew 23.21%.
• Year by year, Free Cash Flow stood at -$1.1 million in 2022, then climbed by 8.33% to -$990139.0 in 2023, then sank by 120.53% to -$2.2 million in 2024, then dropped by 6.9% to -$2.3 million in 2025, then grew by 28.18% to -$1.7 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$1.7 million, -$2.3 million, and -$2.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.